CALCULATE YOUR SIP RETURNS

Thyrocare Expands Reach with Acquisition of Vimta Labs’ Diagnostics Business

30 August 20243 mins read by Angel One
Thyrocare acquires Vimta Labs' diagnostics unit to boost its presence in South India, expand market share, and strengthen ties with franchisees and hospitals.
Thyrocare Expands Reach with Acquisition of Vimta Labs’ Diagnostics Business
ShareShare on 1Share on 2Share on 3Share on 4Share on 5

On August 30, 2024, Thyrocare Technologies Limited, a major player in healthcare diagnostics, announced that it had signed a Business Transfer Agreement with Vimta Labs Limited.

This agreement involves Thyrocare acquiring Vimta Labs’ diagnostic and pathological services business.

Key Details Of The Deal

  • Thyrocare will purchase the diagnostic and pathological services business from Vimta Labs.
  • Vimta Labs’ diagnostic business generated revenue of ₹30 crore during fiscal year 2024 and ₹7 crore in revenue for the first quarter of FY 2025.
  • The transaction will be finalised once certain standard conditions are met.

Strategic Reasons Behind The Acquisition

  • Vimta Labs has developed a strong presence in Telangana and enjoys substantial customer loyalty. Thyrocare plans to leverage this established brand to expand its reach while maintaining the Vimta Labs brand.
  • Thyrocare will gain access to 11 Vimta Labs centres located in Telangana, Andhra Pradesh, Uttar Pradesh, and Odisha, including a central processing lab in Hyderabad, which is accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL).
  • This acquisition will help Thyrocare strengthen its footprint in the Southern region of India, allowing it to reach more customers and continue providing high-quality, affordable diagnostic services.

“I am pleased to announce that we are acquiring the diagnostic and pathological services business of Vimta. This strategic move aligns with our growth objectives, allowing Thyrocare to expand its market share, solidify our leadership position in South India, and grow our business with franchisees and hospitals. Additionally, this expansion will enable Thyrocare to leverage the benefits of scale.” said Mr Rahul Guha, MD & CEO of Thyrocare Technologies Limited

About Thyrocare

Thyrocare Technologies Limited is India’s leading and first fully automated laboratory chain, with a strong presence across the country. Thyrocare is dedicated to offering high-quality, affordable diagnostic services to labs and hospitals throughout India. Numerous labs and hospital brands nationwide rely on the extensive range of tests provided by Thyrocare.

About Vimta

Vimta Labs Limited was originally founded as a partnership firm in 1984. It is India’s most comprehensive contract research and testing organisation, offering various industries a wide range of services. These include biopharmaceuticals, food, consumer goods, electronics, electrical, agrochemicals, healthcare, medical devices, power, cement, oil and gas, ores and minerals, infrastructure, and more.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.

We're Live on WhatsApp! Join our channel for market insights & updates

Open Free Demat Account!

Enjoy Zero Brokerage on Equity Delivery

Join our 2 Cr+ happy customers

+91
Enjoy Zero Brokerage on Equity Delivery
4.4 Cr+DOWNLOADS
Enjoy Zero Brokerage on Equity Delivery

Get the link to download the App

Send App Link
Open Free Demat Account!
Enjoy Zero Brokerage on Stock Investments.